금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
The 30-year Treasury yield is closing in on 5.2%. A surge to 6% could slam stocks.
Long-bond yield spike is increasingly possible — threatening to deepen losses for popular long-term ...
European Central Bank: September hike risk rises with oil and PMIs – Commerzbank
Commerzbank analysts highlight that ECB President Lagarde has opened the door to a September rate hi...
Pershing Square Inc. declares $0.122 dividend
U.S. drilling rigs rise by 7 for 10th gain in 11 weeks, Baker Hughes says
Shift4 Payments, Inc. 6 SER A CNV PREF declares $1.50 dividend
Veteran manager sends blunt take on buying the June swoon in July
I do not want investors to worry about the selloff in AI and data center-related stocks that commenced in late June. If you decided to sell the AI and data center stocks, you literally have nowhere to ...
AEVEX Lands A New Deal, And A New Narrative
A new Air Force contract sent the stock soaring, but investors were reading between the lines of this particular win.
S&P 500 Posts Weekly Rise Ahead of Fourth of July, Led by Communication Services
The Standard & Poor's 500 index rose 1.8% this week, led by gains in communication services and fina
Navient reports data breach involving third-party law firm
Update: US Equity Indexes Mixed as Weak Jobs Data Trigger Rotation Out of Growth Stocks
(Updates with index/price moves, macroeconomic data, and company news from the first paragraph.)
The stock market is realizing there won’t be a rate hike – analyst
Why maxing out your 401(k) is a major financial mistake if you have credit-card and other punishing debt
Grabbing an employer match is essential, but prioritizing high-interest debt and emergency cash can bring much better near-term results.
Standex acquires remaining 9.9% stake in India's Narayan Powertech for $64M
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, July 02, 2026--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the grant o ...